Entrar Registro gratuito

Guided Therapeutics Dinheiro/Ação

Qual é o Dinheiro/Ação de Guided Therapeutics?

O Dinheiro/Ação de Guided Therapeutics, Inc. é 0.06

Qual é a definição de Dinheiro/Ação?

Dinheiro por ação é o dinheiro em caixa de uma empresa dividido pelas ações da empresa em circulação.

Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.

When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.

Dinheiro/Ação de empresas na Setor Health Care em OTC em comparação com Guided Therapeutics

O que Guided Therapeutics faz?

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Empresas com dinheiro/ação semelhantes a Guided Therapeutics